Debt-to-equity in % of Tenaya Therapeutics, Inc. from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tenaya Therapeutics, Inc. quarterly Debt-to-equity history and change rate from Q1 2022 to Q3 2025.
  • Tenaya Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 24.3 %, a 15.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Tenaya Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 24.3 +3.2 +15.1% 30 Sep 2025
Q2 2025 24 +4.64 +24% 30 Jun 2025
Q1 2025 23.7 +5.76 +32.1% 31 Mar 2025
Q4 2024 22.3 +5.34 +31.5% 31 Dec 2024
Q3 2024 21.1 +5.79 +37.7% 30 Sep 2024
Q2 2024 19.4 +4.42 +29.6% 30 Jun 2024
Q1 2024 18 +3.44 +23.7% 31 Mar 2024
Q4 2023 17 +2.71 +19% 31 Dec 2023
Q3 2023 15.3 +1.62 +11.8% 30 Sep 2023
Q2 2023 15 +2.79 +23% 30 Jun 2023
Q1 2023 14.5 -2.21 -13.2% 31 Mar 2023
Q4 2022 14.3 31 Dec 2022
Q3 2022 13.7 30 Sep 2022
Q2 2022 12.2 30 Jun 2022
Q1 2022 16.7 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.